BURLINGTON, Mass., March 10 /PRNewswire/ -- InfraReDx, Inc., an innovative medical device company focused on developing novel diagnostic imaging technologies to accurately identify and characterize diseased intracoronary tissues, today announced that the Company’s LipiScan(TM) Coronary Imaging System will be highlighted in multiple sessions during the 59th Annual Scientific Session of the American College of Cardiology (ACC). The meeting, named ACC.10 and i2 Summit, is being held from March 14 - 16, 2010 at the Georgia World Congress Center in Atlanta. In addition to several oral presentations featuring LipiScan, InfraReDx has organized a “Meet the Experts” series of discussions at the Company’s booth (#254) in which leading cardiologists will highlight LipiScan’s capabilities in identifying and characterizing lipid core (fatty) plaque.
“One of the biggest challenges facing interventional cardiologists today is the ability to detect vulnerable coronary and fatty plaques,” said Brijeshwar S. Maini, M.D., F.A.C.C, co-chair cardiovascular research, Pinnacle Health at Harrisburg Hospital. “As a result of improved imaging and diagnostic capabilities, however, physicians can now be armed with that information and are able to make important advances and improvements in patient care. This year’s ACC meeting provides us with a great opportunity to interact with our colleagues, share key learnings and discuss important steps forward.”
The schedule of scientific sessions and “Meet the Experts” discussions to feature LipiScan is as follows.
Sunday, March 14:
8:00 a.m. - 9:30 a.m., Session #2092, Room B310
Session title: Imaging and Vulnerable Plaque
Presentation title: Association of Large Lipid Core Plaque Detected by Near Infrared Spectroscopy with Post Percutaneous Coronary Intervention Myocardial Infarction
Presenter: Brijeshwar S. Maini, M.D., F.A.C.C, co-chair cardiovascular research, Pinnacle Health at Harrisburg Hospital
InfraReDx “Meet The Experts” series:
Noon - 1:00 p.m., Exhibit Hall: ACC Lunch & Learn
“Lipid Core Plaque Modification”
Expert: Brijeshwar S. Maini, M.D., F.A.C.C, co-chair cardiovascular research, Pinnacle Health at Harrisburg Hospital
3:30 p.m. - 4:30 p.m., Exhibit Hall: Poster Hour
“Pick the Peri-Stenting MI”
Expert: James E. Muller, M.D., founder and chief executive officer of InfraReDx
Noon - 1:00 p.m., InfraReDx Booth #254
“Stent Length Placement & Distal Embolization”
Expert: James Goldstein, M.D., director of research and education, Division of Cardiology, William Beaumont Hospital
3:30 p.m. - 4:30 p.m., InfraReDx Booth #254
“PROSPECT Trial and the Vulnerable Plaque”
Expert: James E. Muller, M.D., founder and chief executive officer of InfraReDx
Noon - 1:00 p.m., InfraReDx Booth # 254
“Advances in Intra-coronary Imaging in the Past Year - NIR, IVUS, OCT and Others”
Expert: James E. Muller, M.D., founder and chief executive officer of InfraReDx
About InfraReDx, Inc.
InfraReDx, Inc., headquartered in Burlington, Massachusetts, is a privately-funded medical device company founded in 1998 and focused on intravascular characterization of disease in the coronary arteries. InfraReDx is the maker of the LipiScan(TM) system, a novel near-infrared (NIR) spectroscopy catheter that can detect the lipid core coronary plaques suspected to cause most heart attacks and known to complicate stenting procedures. For more information, visit www.infraredx.com.
InfraReDx, Inc.
